Roche recently announced that it will invest $50 billion in the United States over the next five years. These investments further strengthen Roche's already significant footprint in the U.S., where it has 13 manufacturing and 15 research and development sites in the pharmaceutical and diagnostics sectors. It is expected to create over 12,000 new jobs, including nearly 6,500 construction jobs and 1,000 positions for the building and expansion of facilities.

U.S. President Trump delivered a speech in a public venue on Tuesday (April 22) local time,He acknowledged that the current tariffs on imports from China are too high and predicted a significant reduction in tariff rates.This marks a shift in Trump's attitude towards his signature tariff policy. On Tuesday, U.S. Treasury Secretary Becerra also stated at a JPMorgan event that the trade war between China and the U.S. will soon cool down.

On April 22, local time, the International Monetary Fund released the latest World Economic Outlook report, lowering its global economic growth forecast for 2025 from 3.3% at the beginning of the year to 2.8%. The projection for 2026 is expected to be 3%. The impact of U.S. tariff measures and policy uncertainties will lead to a significant slowdown in the global economy in the short term.

On April 21, Zimmer Biomet, a global leader in orthopedics (NYSE: ZBH), announced the completion of its acquisition of Paragon 28. The deal is valued at $1.2 billion (approximately 8.7 billion RMB). Paragon 28 offers a wide range of surgical products and systems covering all major areas of the foot and ankle, including fractures and trauma, deformity correction, as well as joint replacement.

At today's Contemporary Amperex Technology Company (CATL) Super Tech Day, the second-generation Shengxing ultra-fast charging battery was officially unveiled. As the world's first lithium iron phosphate battery to achieve both an 800 km range and a peak charging rate of 12C, this product utilizes supercrystalline graphite and carbon-coated nano-superconducting technology, offering impressive charging speed—75 km of range can be added in just 30 seconds, and after 5 minutes of charging, the vehicle can travel 520 km. The peak power exceeds 1.3 megawatts. Additionally, the battery performs excellently in low-temperature environments; at -10°C, it can charge from 5% to 80% in 15 minutes, and it supports full-range temperature and full state-of-charge (SOC) power output. Even in a low SOC state (20%), it can still maintain a high power demand of 830 kW. This release further solidifies CATL's leading position in the field of power battery technology.

Recently, Edwards Lifesciences announced that it...The world's firstThe transcatheter mitral valve replacement (TMVR) implant system Sapien M3, which accesses through the femoral vein, has received European CE certification. It is understood that Sapien M3 is an innovative product for transcatheter mitral valve replacement, mainly consisting of a fixation base and the SAPIEN M3 valve. The approved indication covers this procedure.Patients with moderate-to-severe and severe mitral regurgitation (MR)These patients cannot tolerate open chest surgery or transcatheter edge-to-edge repair (TEER) treatment.

China LogisticsThe Procurement Association issued a statement opposing the U.S. Section 301 investigation measures in the logistics, maritime, and shipbuilding sectors: On April 17 local time, the U.S. Trade Representative's Office announced...China LogisticsThe final measures on the Section 301 investigation into maritime and shipbuilding sectors have obvious characteristics of unilateralism and protectionism, severely undermining the multilateral trading system and international trade rules.China Logistics The China Council for the Promotion of International Trade and the China Chamber of International Commerce solemnly declare their strong opposition to the U.S. invoking the Section 301 investigation as a pretext to...China Logistics , and the restrictive measures taken in the fields of maritime affairs and shipbuilding. We urge the US side to respect the market rules and multilateral trade rules, and immediately correct its wrong practices.

The automotive industry report indicates that the market penetration rate of cars equipped with combination driving assistance functions in our country is rapidly increasing, having entered the stage of large-scale application. The market penetration rate has risen from 23.5% in 2021 to 57.3% in 2024. It is expected that this year the market penetration rate for L2 level vehicles, which have partial autonomous driving functions, will likely exceed 70%. In addition, the importance of intelligent cockpit technology is also growing day by day. The report also points out that the penetration rates of intelligent cockpits in new vehicles in China and globally have climbed to 73% and 58%, respectively, exceeding half of the market share.

The new tea beverage brand Bawang Chaji has announced a partnership with Fuller Technology to optimize logistics management using the FLUX TMS solution. This system will cover trunk transportation, urban distribution, international logistics, and other full-link operations, achieving cost reduction and efficiency improvement through intelligent scheduling, route planning, and resource integration. This collaboration coincides with Bawang Chaji's listing on NASDAQ, making it the first new-style tea beverage company to go public in the U.S. stock market, marking a new phase in its globalization strategy. The visualization capabilities of FLUX TMS will further enhance supply chain transparency and provide solid support for overseas market expansion.

Recently, Shanghai Eastray New Materials Co., Ltd. (referred to as "Eastray New Materials") has completed its IPO tutoring filing with the Shanghai branch of the China Securities Regulatory Commission (CSRC). The tutoring institution is Kaiyuan Securities. As a national-level specialized, refined, unique, and innovative "Little Giant" enterprise, Eastray New Materials focuses on the research, production, and sales of functional high polymer hot melt adhesive materials. The company was established in 2010, with a registered capital of RMB 61.91 million. The actual controllers are Mr. Jin Jingdong and Ms. Guan Lu, who are a couple, holding a combined stake of 72.7%. Among them, Mr. Jin Jingdong serves as the chairman and general manager, directly holding 43.6% of the shares, and he possesses rich industry experience; Ms. Guan Lu currently serves as the director of the human resources department.

According to the Tianyancha APP data, Yili Group (600887) has newly obtained an industrial design patent authorization. The patent is named "Packaging Box (Classic Four-Cup Set)," with the application number CN202430558570.7, and the authorization date is April 18, 2025. So far this year, Yili Group has obtained 115 new patent authorizations, marking a 51.32% increase compared to the same period last year. According to the company’s 2024 mid-year financial report, Yili invested 341 million yuan in research and development in the first half of 2024, representing a year-on-year decrease of 0.67%.

On April 16th local time, Abbott announced its financial results for the first quarter of 2025. The report shows that Abbott's net sales in the first quarter reached 10.36 billion US dollars, a year-on-year increase of 4%. Among them, the medical device segment has the highest proportion, with revenue of 4.895 billion US dollars, a year-on-year increase of 9.9%; the nutrition business revenue was 2.146 billion US dollars, a year-on-year increase of 3.8%; the generic drug business revenue was 1.26 billion US dollars, a year-on-year increase of 2.7%; the diagnostic business was affected by the decline in demand for COVID-19 testing, with a year-on-year decrease of 7.2%, but excluding this factor, the organic growth turned positive to +0.5%.

On April 16, Illumina. The company announced via internal email a global workforce reduction of approximately 3.5% to advance the goal of reducing expenses by $100 million. Based on the employee count of 8,970 at the end of 2024, this round of layoffs will affect...Over 300 people。

On April 16th, global medical device giant Abbott disclosed in a financial report conference call that it expects this year's tariff policies to have an impact of "several hundred million dollars" on the company. Although Abbott did not provide details of the tariff costs, Vijay Kumar, an analyst at the globally renowned investment bank Evercore ISI, estimates that this year's tariffs will bring about $300 million to Abbott. (approximately RMB2.2 billion coinsNegative effects.Among them, the US and Chinese markets will be the main pressure zones. Reuters reported that,China is a major source of raw materials for the pharmaceutical and medical device industries.

On April 15th local time, healthcare giant Johnson & Johnson warned in its financial report that tariffs are expected to result in a $400 million profit loss for the company by 2026, with the medical device division being hit the hardest. "This $400 million loss encompasses several tariff impacts, including import tariffs beyond the scope of the North American Free Trade Agreement from Canada and Mexico, as well as global steel and aluminum tariffs (the latter having a relatively smaller impact). However, tariffs between China and the US undoubtedly account for the largest portion, with products exported from the US to China facing the most significant impact," Volk added.

On April 16, XPeng Motors released its annual report for 2024, stating that the construction of its new production base in Wuhan has been completed and is awaiting final inspection and acceptance by relevant government departments. The same day, XPeng Motors also released its ESG report, noting that since its establishment, the company has invested over 500 billion yuan in research and development and manufacturing in the field of intelligent vehicles. In 2025, XPeng Motors will invest more than 6 billion yuan in technology research and development.

At today's regular press conference of the Ministry of Foreign Affairs, a reporter asked about the latest statement on the White House's official website, which indicated that due to China's retaliatory measures, the U.S. has increased tariffs on China to 245%. In response, Foreign Ministry spokesperson Lin Jian stated that for specific tariff rates, you may ask the U.S. side. China has repeatedly clarified its firm stance on the issue of tariffs. This tariff war was initiated by the U.S., and China has taken necessary countermeasures to safeguard its legitimate rights and interests as well as international fairness and justice, which is completely reasonable and lawful. There are no winners in a tariff war or trade war. China does not wish to fight, but will never shy away from it.

On April 16, at the regular press conference of the Ministry of Foreign Affairs, a journalist asked about the latest statement on the US White House website, which said that due to China's retaliatory measures, the US tariffs on Chinese goods have been increased to 245%. In response, Foreign Ministry spokesperson Lin Jian stated that for specific tariff figures, you may want to ask the US side. China has repeatedly clarified its solemn position on the issue of tariffs. The tariff war was initiated by the US side, and China has taken necessary countermeasures to safeguard its own legitimate rights and interests and international fairness and justice, which is entirely reasonable and legal. There is no winner in a tariff war or a trade war. China does not want to fight one, but it is also absolutely unafraid to do so.

On April 16th, the National Bureau of Statistics released economic data for the first quarter of 2025. Preliminary calculations show that the Gross Domestic Product (GDP) for the first quarter was 31,875.8 billion yuan, a year-on-year increase of 5.4%, and a increase of 1.2% compared to the fourth quarter of the previous year. It ranks among the top in the world's major economies. In the first quarter, the value added by industrial enterprises above designated size grew by 6.5% year-on-year. In March, the actual increase compared to the same period last year was 7.7%.

Recently, Terumo Neuro, a wholly-owned subsidiary of Terumo Corporation, a global leader in neurovascular innovation, announced that its carotid artery stent system has received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA). Notably, this product is a groundbreaking medical device, marking the first of its kind in the U.S. market.The first certified double-layer micro-mesh carotid artery stent systemProvided a new clinical solution for the treatment of carotid artery disease.